Chest Pain Symptoms Differences Between Diabetic Patients and Non
Launched by ASSIUT UNIVERSITY · Dec 4, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how chest pain symptoms differ between patients with diabetes and those without it. Researchers want to understand why some people with diabetes may not feel chest pain, even when they have serious heart problems. This is important because heart disease is a leading cause of death worldwide, and recognizing symptoms early can save lives.
To participate in the trial, you need to be at least 30 years old and diagnosed with a type of heart attack called STEMI or NSTEMI. You should be stable, meaning your condition is not worsening, and you should not have serious complications like heart failure or certain heart rhythm problems. If you join, you can expect to share your experiences and symptoms related to chest pain, which will help researchers learn more about how diabetes affects heart disease. Your participation could contribute to better understanding and treatment of heart issues in people with diabetes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • i) Patients diagnosed with STEMI and NSTEMI ii) Both genders iii) above the age of 30 years iv) Patients with acute myocardial infarction with or without chest pain (angina) for 24 hours v) patients who are hemodynamically stable vi) patients without acute decompensated heart failure (ADHF) vii) patients without malignant arrhythmias viii) patients without in Acute Lung Oedem (ALO) condition ix) patients not using ventilator x) patient willing to and become respondents.
- Exclusion Criteria:
- • i) Patients with several complications, thereby making it impossible to interview them ii) patients who have never undergone CABG surgery iii) patients who refuse to be respondents
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Trial Officials
Essam El-dien M Abdullah, MD
Study Director
Assiut University
Zeinab Abd-Elatiff, MD
Study Director
Ismailia Universiry
Khalid Abdelbaky, MD
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported